R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.
Read More…
Industry, Sector and Symbol
Industry Management services
Sub-IndustryHealth Care Services
SectorFinance
Phone312-324-7820
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$868.50 million
Profitability
Miscellaneous
Employees18,600
Next Earnings Date11/6/2019 (Estimated)
OptionableNot Optionable
R1 RCM (NASDAQ:RCM) Frequently Asked Questions
What is R1 RCM's stock symbol?
R1 RCM trades on the NASDAQ under the ticker symbol "RCM."
How were R1 RCM's earnings last quarter?
R1 RCM Inc (NASDAQ:RCM) posted its quarterly earnings results on Tuesday, August, 6th. The financial services provider reported ($0.09) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.01) by $0.08. The financial services provider earned $295 million during the quarter, compared to analyst estimates of $294.11 million. R1 RCM had a negative net margin of 2.22% and a negative return on equity of 249.01%. The firm's quarterly revenue was up 41.9% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.07) earnings per share. View R1 RCM's Earnings History.
When is R1 RCM's next earnings date?
What guidance has R1 RCM issued on next quarter's earnings?
R1 RCM issued an update on its FY 2019 earnings guidance on Tuesday, August, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.15-1.25 billion, compared to the consensus revenue estimate of $1.22 billion.
What price target have analysts set for RCM?
4 brokers have issued 1 year price targets for R1 RCM's shares. Their predictions range from $10.00 to $20.00. On average, they anticipate R1 RCM's share price to reach $14.25 in the next twelve months. This suggests a possible upside of 36.8% from the stock's current price. View Analyst Price Targets for R1 RCM.
What is the consensus analysts' recommendation for R1 RCM?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for R1 RCM.
What are Wall Street analysts saying about R1 RCM stock?
Here are some recent quotes from research analysts about R1 RCM stock:
- 1. According to Zacks Investment Research, "R1 RCM Inc. offers financial services for the health care industries. The Company provides revenue cycle management and physician advisory services, as well as transforms and manages the commercial infrastructure of health care organizations. R1 RCM Inc., formerly known as Accretive Health, Inc., is headquartered in Chicago, Illinois. " (8/13/2019)
- 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on RCM shares and maintain our 12-mo. PT of $13. We recently attended a comprehensive webinar hosted by R1 RCM, titled Intelligent Driving a New Level of Revenue Cycle Performance". During the session, we were provided a background on automation followed by a more detailed view into how R1 is using automation to drive performance for its provider clients. We continue to believe there is significant opportunity for automation to generate value for providers. R1 has an impressive digital offering, which we believe provides a competitive edge. We believe these efforts should drive solid top-line growth and margin expansion long term." (4/12/2019)
Has R1 RCM been receiving favorable news coverage?
Headlines about RCM stock have trended negative this week, according to InfoTrie. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. R1 RCM earned a coverage optimism score of -2.9 on InfoTrie's scale. They also assigned news articles about the financial services provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for R1 RCM.
Who are some of R1 RCM's key competitors?
What other stocks do shareholders of R1 RCM own?
Who are R1 RCM's key executives?
R1 RCM's management team includes the folowing people:
- Mr. Joseph Gerard Flanagan, Pres, CEO & Director (Age 48)
- Mr. Christopher Simon Ricaurte, CFO & Treasurer (Age 59)
- Mr. Gary S. Long, Exec. VP & Chief Commercial Officer (Age 49)
- Mr. Richard B. Evans Jr., Principal Accounting Officer, Sr. VP & Corp. Controller (Age 51)
- Mr. Atif A. Rahim, Sr. VP of Investor Relations & Bus. Devel.
Who are R1 RCM's major shareholders?
R1 RCM's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.62%), Paradigm Capital Management Inc. NY (4.60%), Vanguard Group Inc. (4.28%), Eversept Partners LP (2.41%), Bank of New York Mellon Corp (1.89%) and Allianz Asset Management GmbH (1.78%). Company insiders that own R1 RCM stock include Albert Rene Zimmerli and Charles J Ditkoff. View Institutional Ownership Trends for R1 RCM.
Which institutional investors are selling R1 RCM stock?
RCM stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Paradigm Capital Management Inc. NY, Park West Asset Management LLC, Penn Capital Management Co. Inc., Eversept Partners LP, BlackRock Inc., Wetherby Asset Management Inc. and University of Notre Dame DU Lac. View Insider Buying and Selling for R1 RCM.
Which institutional investors are buying R1 RCM stock?
RCM stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Citadel Advisors LLC, SG Americas Securities LLC, Nuveen Asset Management LLC, RK Capital Management LLC, Russell Investments Group Ltd., Falcon Point Capital LLC and Allianz Asset Management GmbH. View Insider Buying and Selling for R1 RCM.
How do I buy shares of R1 RCM?
Shares of RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is R1 RCM's stock price today?
One share of RCM stock can currently be purchased for approximately $10.42.
How big of a company is R1 RCM?
R1 RCM has a market capitalization of $1.17 billion and generates $868.50 million in revenue each year. The financial services provider earns $-45,300,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. R1 RCM employs 18,600 workers across the globe.View Additional Information About R1 RCM.
What is R1 RCM's official website?
How can I contact R1 RCM?
R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The financial services provider can be reached via phone at 312-324-7820 or via email at [email protected]
MarketBeat Community Rating for R1 RCM (NASDAQ RCM)
MarketBeat's community ratings are surveys of what our community members think about R1 RCM and other stocks. Vote "Outperform" if you believe RCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
